Ophthalmic Case Studies and Novel Approach
In a recent small-scale randomized controlled trial, the Oculeve Intranasal Lacrimal Neurostimulator (Allergan) was found to increase the production of aqueous tears and the secretion of goblet cells. This handheld device functions by administering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve within the nasal cavities. This innovative approach presents a potential new avenue for managing dry eye disease, which currently relies heavily on artificial tears and anti-inflammatory medications.
Related Conference of Ophthalmic Case Studies and Novel Approach
July 07-08, 2025
9th International Conference & Expo on Euro Optometry and Vision Science
Zurich, Switzerland
September 16-17, 2025
20th International Conference on Ophthalmology and Vision Science
Amsterdam, Netherlands
Ophthalmic Case Studies and Novel Approach Conference Speakers
Recommended Sessions
- Corona Virus Effect on EYE
- Glaucoma Surgery
- Neuroscience of Visual Impairment
- Pediatric Ophthalmology
- Recent Researches in Vision Science and Ophthalmology
- Clinical Ophthalmology
- Congenital cataracts
- Cornea Disorders and Treatments
- Diagnostic Instruments in Optometry
- Effect of Digital Screens on Eye
- Eye Health
- Infant vision
- Ophthalmic Case Studies and Novel Approach
- Ophthalmology
- Optometry and Vision science
- Perception and Visual Cognition
- Refractive Surgery
- Retinal care
- Scrutiny of Visual Sensory System
- Vision Science and Technology of Ophthalmology
- Vitreous and Ophthalmic Epidemiology
Related Journals
Are you interested in
- Advances in Glaucoma Treatment - OPTOMETRY MEET 2025 (UK)
- AI in Ophthalmology - OPTOMETRY MEET 2025 (UK)
- Artificial Intelligence and Deep Learning in Ophthalmology - Euro Optometry 2025 (Switzerland)
- Cataract: Vision Problem - Euro Optometry 2025 (Switzerland)
- Cornea Disorders and Treatments - Euro Optometry 2025 (Switzerland)
- Digital Eye Strain and Blue Light Exposure - OPTOMETRY MEET 2025 (UK)
- Dry Eye Disease Management - OPTOMETRY MEET 2025 (UK)
- Effect of Digital Screens on Eye - Euro Optometry 2025 (Switzerland)
- Gene Therapy for Ocular Diseases - OPTOMETRY MEET 2025 (UK)
- Geriatric Optometry - OPTOMETRY MEET 2025 (UK)
- Glaucoma - Euro Optometry 2025 (Switzerland)
- Innovations in Contact Lens Design - OPTOMETRY MEET 2025 (UK)
- Latest and Innovative Eye Research - Euro Optometry 2025 (Switzerland)
- Macular Degeneration - Euro Optometry 2025 (Switzerland)
- Myopia management - OPTOMETRY MEET 2025 (UK)
- Myopia Management - Euro Optometry 2025 (Switzerland)
- Nano Ophthalmology - Euro Optometry 2025 (Switzerland)
- Neuro-ophthalmology - Euro Optometry 2025 (Switzerland)
- Nutrition and Eye Health - OPTOMETRY MEET 2025 (UK)
- Ocular Diseases - Euro Optometry 2025 (Switzerland)
- Ocular Oncology - OPTOMETRY MEET 2025 (UK)
- Ophthalmic Lenses and Laser Treatment - Euro Optometry 2025 (Switzerland)
- Ophthalmology - OPTOMETRY MEET 2025 (UK)
- Ophthalmology Surgery - Euro Optometry 2025 (Switzerland)
- Optometry and Vision Science - Euro Optometry 2025 (Switzerland)
- Pediatric Ophthalmology - Euro Optometry 2025 (Switzerland)
- Pediatric optometry - OPTOMETRY MEET 2025 (UK)
- Refractive Errors and Disorders - Euro Optometry 2025 (Switzerland)
- Regenerative Medicine in Eye Care - OPTOMETRY MEET 2025 (UK)
- Retina & its Disorders - Euro Optometry 2025 (Switzerland)
- Retinal Imaging and Innovations - OPTOMETRY MEET 2025 (UK)
- Strabismus - Euro Optometry 2025 (Switzerland)
- Sustainability in Ophthalmology - OPTOMETRY MEET 2025 (UK)
- Uveitis - Euro Optometry 2025 (Switzerland)
- Vision rehabilitation - Euro Optometry 2025 (Switzerland)